RBPWorld - a comprehensive database of RNA Binding Proteins

Drugs target to PPIA

Drug name	Drug type	Disease/phenotype	Mechanism of action(MoA)	Phase	Status	Source
ALISPORIVIR	Protein	hepatitis C virus infection	Cyclophilin A inhibitor	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	chronic kidney disease	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	eye disease	Cyclophilin A modulator	3.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	keratoconjunctivitis	Cyclophilin A modulator	4.0	-	DailyMed
CYCLOSPORINE	Protein	epidermolysis bullosa	Cyclophilin A modulator	1.0	Active, not recruiting	ClinicalTrials
CYCLOSPORINE	Protein	dry eye syndrome	Cyclophilin A modulator	4.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	bronchiolitis obliterans	Cyclophilin A modulator	3.0	Enrolling by invitation	ClinicalTrials
CYCLOSPORINE	Protein	Aplastic anemia	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	inflammation	Cyclophilin A modulator	4.0	-	DailyMed
CYCLOSPORINE	Protein	eye disease	Cyclophilin A modulator	1.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	rheumatoid arthritis	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Acute kidney injury	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	chronic lymphocytic leukemia	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	myocarditis	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	psoriasis	Cyclophilin A modulator	4.0	Not yet recruiting	ClinicalTrials
CYCLOSPORINE	Protein	neoplasm	Cyclophilin A modulator	1.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	atopic eczema	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	renal cell carcinoma	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	multiple myeloma	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	membranous glomerulonephritis	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	atopic eczema	Cyclophilin A modulator	4.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	chronic myeloproliferative disorder	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	non-Hodgkins lymphoma	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	dry eye syndrome	Cyclophilin A modulator	4.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	Waldenstrom macroglobulinemia	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	myelodysplastic/myeloproliferative disease	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	chronic hepatitis C virus infection	Cyclophilin A modulator	3.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	severe aplastic anemia	Cyclophilin A modulator	3.0	Not yet recruiting	ClinicalTrials
CYCLOSPORINE	Protein	interstitial cystitis	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	colorectal carcinoma	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	kidney disease	Cyclophilin A modulator	4.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	lymphoma	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	dry eye syndrome	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	myelodysplastic syndrome	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	neoplasm	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	chronic kidney disease	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	dry eye syndrome	Cyclophilin A modulator	4.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	neoplasm	Cyclophilin A modulator	2.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	Lymphoma, AIDS-Related	Cyclophilin A modulator	2.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	Aplastic anemia	Cyclophilin A modulator	2.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	colorectal adenocarcinoma	Cyclophilin A modulator	1.0	Active, not recruiting	ClinicalTrials
CYCLOSPORINE	Protein	diffuse large B-cell lymphoma	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	follicular lymphoma	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	membranous glomerulonephritis	Cyclophilin A modulator	4.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	T-Cell Prolymphocytic Leukemia	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	dry eye syndrome	Cyclophilin A modulator	4.0	Not yet recruiting	ClinicalTrials
CYCLOSPORINE	Protein	lymphoblastic lymphoma	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	skin cancer	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	immune deficiency disease	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	adult acute lymphoblastic leukemia	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	type 2 diabetes mellitus	Cyclophilin A modulator	4.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	hepatitis C virus infection	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	nodal marginal zone B-cell lymphoma	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	atopic eczema	Cyclophilin A modulator	4.0	Not yet recruiting	ClinicalTrials
CYCLOSPORINE	Protein	lymphoid neoplasm	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	ischemia reperfusion injury	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Fanconi anemia	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Aplastic anemia	Cyclophilin A modulator	1.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	atopic eczema	Cyclophilin A modulator	4.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	hepatitis C virus infection	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	breast cancer	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
SCY 635	Protein	hepatitis C virus infection	Cyclophilin A inhibitor	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	non-Hodgkins lymphoma	Cyclophilin A modulator	2.0	Active, not recruiting	ClinicalTrials
CYCLOSPORINE	Protein	severe aplastic anemia	Cyclophilin A modulator	2.0	Active, not recruiting	ClinicalTrials
CYCLOSPORINE	Protein	childhood acute lymphoblastic leukemia	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	leukemia	Cyclophilin A modulator	2.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	breast cancer	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	22q11.2 deletion syndrome	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	lymphoma	Cyclophilin A modulator	2.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	heart disease	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Mantle cell lymphoma	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	rheumatoid arthritis	Cyclophilin A modulator	3.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	lymphoid neoplasm	Cyclophilin A modulator	2.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	chronic myelogenous leukemia	Cyclophilin A modulator	1.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	severe aplastic anemia	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Mantle cell lymphoma	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Aplastic anemia	Cyclophilin A modulator	2.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	Aplastic anemia	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	thrombotic thrombocytopenic purpura	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	acute graft vs. host disease	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	inflammation	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	acute lymphoblastic leukemia	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	leukemia	Cyclophilin A modulator	1.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	rosacea	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	post-transplant lymphoproliferative disease	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	chronic myelogenous leukemia	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	acute graft vs. host disease	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	keratitis	Cyclophilin A modulator	4.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	acute myeloid leukemia	Cyclophilin A modulator	2.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	brain neoplasm	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	colorectal carcinoma	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	kidney failure	Cyclophilin A modulator	3.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	Epiphora	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	leukemia	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	pure red-cell aplasia	Cyclophilin A modulator	3.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	lymphoma	Cyclophilin A modulator	1.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	acute myeloid leukemia	Cyclophilin A modulator	3.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	kidney failure	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	brain injury	Cyclophilin A modulator	1.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	brain injury	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Behcet's syndrome	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	neutropenia	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Leber hereditary optic neuropathy	Cyclophilin A modulator	2.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	lymphoma	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	bronchiolitis obliterans	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	mast-cell leukemia	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	pure red-cell aplasia	Cyclophilin A modulator	4.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	severe aplastic anemia	Cyclophilin A modulator	4.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	myelodysplastic syndrome	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	myelodysplastic syndrome	Cyclophilin A modulator	2.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	cardiac arrest	Cyclophilin A modulator	3.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	Eczema	Cyclophilin A modulator	3.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	Aplastic anemia	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	type 2 diabetes mellitus	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	venous thromboembolism	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	fallopian tube cancer	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	leukemia	Cyclophilin A modulator	3.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	type 1 diabetes mellitus	Cyclophilin A modulator	3.0	Enrolling by invitation	ClinicalTrials
CYCLOSPORINE	Protein	diffuse large B-cell lymphoma	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	chronic hepatitis C virus infection	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	psoriasis	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	eye disease	Cyclophilin A modulator	4.0	-	ATC
CYCLOSPORINE	Protein	chronic graft versus host disease	Cyclophilin A modulator	2.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	type 1 diabetes mellitus	Cyclophilin A modulator	2.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	ovarian cancer	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	hereditary angioedema	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Anemia, Hemolytic, Autoimmune	Cyclophilin A modulator	3.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	myelodysplastic syndrome	Cyclophilin A modulator	2.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	myositis	Cyclophilin A modulator	2.0	Not yet recruiting	ClinicalTrials
CYCLOSPORINE	Protein	sarcoma	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	B-Cell Prolymphocytic Leukemia	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Beta-thalassemia	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	multiple myeloma	Cyclophilin A modulator	2.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	skin neoplasm	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	atopic eczema	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	myocardial infarction	Cyclophilin A modulator	2.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	retinal vasculitis	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	graft versus host disease	Cyclophilin A modulator	1.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	focal segmental glomerulosclerosis	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
ALISPORIVIR	Protein	chronic kidney disease	Cyclophilin A inhibitor	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	cutaneous melanoma	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	uveitis	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	periodontitis	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	membranous glomerulonephritis	Cyclophilin A modulator	3.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	graft versus host disease	Cyclophilin A modulator	3.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	Epiphora	Cyclophilin A modulator	2.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	leukemia	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	familial lipoprotein lipase deficiency	Cyclophilin A modulator	2.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	Waldenstrom macroglobulinemia	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	dry eye syndrome	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	small intestine cancer	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	osteogenesis imperfecta	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	chronic graft versus host disease	Cyclophilin A modulator	2.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	childhood acute myeloid leukemia	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
ALISPORIVIR	Protein	chronic hepatitis C virus infection	Cyclophilin A inhibitor	3.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	lymphoma	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
ALISPORIVIR	Protein	liver disease	Cyclophilin A inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYCLOSPORINE	Protein	mucopolysaccharidosis	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	acute myeloid leukemia	Cyclophilin A modulator	3.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	kidney disease	Cyclophilin A modulator	1.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	cardiovascular disease	Cyclophilin A modulator	4.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	neuroblastoma	Cyclophilin A modulator	2.0	Not yet recruiting	ClinicalTrials
CYCLOSPORINE	Protein	membranous glomerulonephritis	Cyclophilin A modulator	3.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	chronic obstructive pulmonary disease	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	severe aplastic anemia	Cyclophilin A modulator	2.0	Not yet recruiting	ClinicalTrials
CYCLOSPORINE	Protein	kidney disease	Cyclophilin A modulator	2.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	leukemia	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	chronic hepatitis C virus infection	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	cardiac arrest	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	hemophagocytic syndrome	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	HIV infection	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	type 1 diabetes mellitus	Cyclophilin A modulator	2.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	leukemia	Cyclophilin A modulator	3.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	Abdominal Aortic Aneurysm	Cyclophilin A modulator	2.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	primary peritoneal carcinoma	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	leukemia	Cyclophilin A modulator	1.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	Henoch-Schoenlein purpura	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	diabetes mellitus	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	lymphoma	Cyclophilin A modulator	3.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	type 1 diabetes mellitus	Cyclophilin A modulator	3.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	diffuse large B-cell lymphoma	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	myeloid neoplasm	Cyclophilin A modulator	2.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	tropical spastic paraparesis	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	dry eye syndrome	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	cutaneous melanoma	Cyclophilin A modulator	1.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	multiple myeloma	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	prostate cancer	Cyclophilin A modulator	1.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	immune system disease	Cyclophilin A modulator	4.0	-	ATC
SCY 635	Protein	chronic hepatitis C virus infection	Cyclophilin A inhibitor	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	22q11.2 deletion syndrome	Cyclophilin A modulator	1.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	multiple myeloma	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	atopic eczema	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	severe aplastic anemia	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	mycosis fungoides	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	type 1 diabetes mellitus	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	graft versus host disease	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	diabetes mellitus	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	Autoimmune Hepatitis	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	systemic inflammatory response syndrome	Cyclophilin A modulator	2.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	cancer	Cyclophilin A modulator	1.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	Sjogren syndrome	Cyclophilin A modulator	4.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	acute myocardial infarction	Cyclophilin A modulator	2.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	glaucoma	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	urticaria	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	hepatitis C virus infection	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	autoimmune thrombocytopenic purpura	Cyclophilin A modulator	2.0	Not yet recruiting	ClinicalTrials
CYCLOSPORINE	Protein	juvenile dermatomyositis	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	leukemia	Cyclophilin A modulator	3.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	psoriasis	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	beta-thalassemia major	Cyclophilin A modulator	4.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	hematopoietic and lymphoid cell neoplasm	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	HIV infection	Cyclophilin A modulator	2.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	chronic lymphocytic leukemia	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	acute graft vs. host disease	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	kidney cancer	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	primary membranoproliferative glomerulonephritis	Cyclophilin A modulator	3.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	pterygium	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	rheumatoid arthritis	Cyclophilin A modulator	1.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	Hodgkins lymphoma	Cyclophilin A modulator	1.0	Active, not recruiting	ClinicalTrials
CYCLOSPORINE	Protein	graft versus host disease	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	dry eye syndrome	Cyclophilin A modulator	3.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	ulcerative colitis	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	aspergillosis	Cyclophilin A modulator	1.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	breast cancer	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	familial lipoprotein lipase deficiency	Cyclophilin A modulator	2.0	Unknown status	ClinicalTrials
ALISPORIVIR	Protein	COVID-19	Cyclophilin A inhibitor	2.0	Not yet recruiting	ClinicalTrials
CYCLOSPORINE	Protein	infection	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	leukemia	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	psoriasis	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Sezary's disease	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	sickle cell anemia	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	psoriasis	Cyclophilin A modulator	2.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	rheumatoid arthritis	Cyclophilin A modulator	4.0	-	DailyMed
ALISPORIVIR	Protein	hepatitis C virus infection	Cyclophilin A inhibitor	3.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	allergic conjunctivitis	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	acute myocardial infarction	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Burkitts lymphoma	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	familial lipoprotein lipase deficiency	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Hodgkins lymphoma	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Myelodysplastic/Myeloproliferative Neoplasm	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	childhood acute lymphoblastic leukemia	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	hepatocellular carcinoma	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	graft versus host disease	Cyclophilin A modulator	2.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	Aplastic anemia	Cyclophilin A modulator	2.0	Active, not recruiting	ClinicalTrials
CYCLOSPORINE	Protein	Stevens-Johnson syndrome	Cyclophilin A modulator	3.0	Not yet recruiting	ClinicalTrials
CYCLOSPORINE	Protein	Crouzon syndrome-acanthosis nigricans syndrome	Cyclophilin A modulator	4.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	atrioventricular septal defect	Cyclophilin A modulator	3.0	Unknown status	ClinicalTrials
ALISPORIVIR	Protein	hepatitis C virus infection	Cyclophilin A inhibitor	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	COVID-19	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Splenic Marginal Zone Lymphoma	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	kidney failure	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	leprosy	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	graft versus host disease	Cyclophilin A modulator	3.0	Not yet recruiting	ClinicalTrials
CYCLOSPORINE	Protein	neuroblastoma	Cyclophilin A modulator	2.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	acute myeloid leukemia	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	lung disease	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	severe aplastic anemia	Cyclophilin A modulator	1.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	dry eye syndrome	Cyclophilin A modulator	4.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	graft versus host disease	Cyclophilin A modulator	3.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	COVID-19	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	hepatocellular carcinoma	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	hepatitis C virus infection	Cyclophilin A modulator	4.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	autoimmune thrombocytopenic purpura	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	skin cancer	Cyclophilin A modulator	4.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	multiple myeloma	Cyclophilin A modulator	1.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	acute myeloid leukemia	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	therapy related acute myeloid leukemia and myelodysplastic syndrome	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	dry eye syndrome	Cyclophilin A modulator	0.5	Not yet recruiting	ClinicalTrials
CYCLOSPORINE	Protein	allergic conjunctivitis	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	autoimmune thrombocytopenic purpura	Cyclophilin A modulator	3.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	viral disease	Cyclophilin A modulator	4.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	allergic conjunctivitis	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	graft versus host disease	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Burkitts lymphoma	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Polyomavirus infectious disease	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	myelodysplastic syndrome	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	psoriasis	Cyclophilin A modulator	4.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	lymphoid neoplasm	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	severe aplastic anemia	Cyclophilin A modulator	2.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	retinoblastoma	Cyclophilin A modulator	2.0	Active, not recruiting	ClinicalTrials
CYCLOSPORINE	Protein	acute myeloid leukemia	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	liver disease	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	acute graft vs. host disease	Cyclophilin A modulator	3.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	bronchiolitis obliterans	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	non-Hodgkins lymphoma	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	graft versus host disease	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	graft versus host disease	Cyclophilin A modulator	2.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	Respiratory Syncytial Virus Infection	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	acute graft vs. host disease	Cyclophilin A modulator	3.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	metastasis	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	chronic kidney disease	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	chronic kidney disease	Cyclophilin A modulator	3.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	lymphoma	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	psoriasis	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	neuroepithelial neoplasm	Cyclophilin A modulator	0.5	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	Aplastic anemia	Cyclophilin A modulator	4.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	prostate cancer	Cyclophilin A modulator	2.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	hemophagocytic syndrome	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	chronic myelogenous leukemia	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	breast cancer	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	psoriasis	Cyclophilin A modulator	4.0	-	DailyMed
CYCLOSPORINE	Protein	myelodysplastic syndrome	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
ALISPORIVIR	Protein	chronic hepatitis C virus infection	Cyclophilin A inhibitor	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	chronic kidney disease	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	Stevens-Johnson syndrome	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	COVID-19	Cyclophilin A modulator	1.0	Not yet recruiting	ClinicalTrials
CYCLOSPORINE	Protein	dry eye syndrome	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	acute lymphoblastic leukemia	Cyclophilin A modulator	3.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	severe acute respiratory syndrome	Cyclophilin A modulator	2.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	acquired aplastic anemia	Cyclophilin A modulator	3.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	dry eye syndrome	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	psoriasis	Cyclophilin A modulator	2.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	bronchiolitis obliterans	Cyclophilin A modulator	0.5	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	lupus nephritis	Cyclophilin A modulator	3.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	chronic granulomatous disease	Cyclophilin A modulator	2.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	multiple myeloma	Cyclophilin A modulator	1.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	myelodysplastic syndrome	Cyclophilin A modulator	4.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	breast cancer	Cyclophilin A modulator	1.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	beta-thalassemia major	Cyclophilin A modulator	4.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	COVID-19	Cyclophilin A modulator	2.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	bronchiolitis obliterans	Cyclophilin A modulator	3.0	Recruiting	ClinicalTrials
CYCLOSPORINE	Protein	chronic hepatitis C virus infection	Cyclophilin A modulator	4.0	Unknown status	ClinicalTrials
CYCLOSPORINE	Protein	allergic conjunctivitis	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	autoimmune thrombocytopenic purpura	Cyclophilin A modulator	3.0	Withdrawn	ClinicalTrials
CYCLOSPORINE	Protein	kidney cancer	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	Aplastic anemia	Cyclophilin A modulator	1.0	Terminated	ClinicalTrials
CYCLOSPORINE	Protein	kidney cancer	Cyclophilin A modulator	1.0	Completed	ClinicalTrials
CYCLOSPORINE	Protein	T-cell large granular lymphocyte leukemia	Cyclophilin A modulator	2.0	Terminated	ClinicalTrials
ALISPORIVIR	Protein	hepatitis C virus infection	Cyclophilin A inhibitor	2.0	Completed	ClinicalTrials

Welcome to

RBP World!

Drugs target to PPIA

Targets details